Morgan Lewis consultant Paul Ranson authored an article for European Pharmaceutical Review in which he explores the reasons behind the introduction of the EU Medical Device and In Vitro Diagnostic Devices Regulations. Paul examines issues with the regulations, including the impact of the coronavirus (COVID-19), which ultimately convinced the Commission that another year of preparation would be needed to fully apply them.